Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

China flag China · Delayed Price · Currency is CNY
27.33
-0.07 (-0.26%)
At close: Dec 5, 2025
-7.89%
Market Cap 25.16B
Revenue (ttm) 6.14B
Net Income (ttm) 1.65B
Shares Out 920.66M
EPS (ttm) 1.80
PE Ratio 15.21
Forward PE 11.68
Dividend 2.09 (7.63%)
Ex-Dividend Date Jun 30, 2025
Volume 6,537,800
Average Volume 10,796,930
Open 27.43
Previous Close 27.40
Day's Range 26.99 - 27.55
52-Week Range 24.20 - 31.38
Beta 0.05
RSI 60.49
Earnings Date Apr 10, 2026

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, neurology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develop... [Read more]

Sector Healthcare
CEO Fei Cao
Employees 5,026
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600566
Full Company Profile

Financial Performance

In 2024, SHA:600566's revenue was 8.02 billion, a decrease of -16.96% compared to the previous year's 9.65 billion. Earnings were 2.53 billion, a decrease of -10.32%.

Financial Statements

News

There is no news available yet.